Manufacturing

Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device fill-finish manufacturing facility at its campus in Hillsboro, Oregon. The…
Read More...

FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing technologies for next-generation antibody-drug conjugates (ADCs), aiming to…
Read More...

Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of SBT-77-7101, an investigational regulatory T cell (Treg) therapy being developed…
Read More...

Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical manufacturing of TSC-101, an investigational T cell receptor-engineered T cell…
Read More...

FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development and manufacturing facility in Madison, Wisconsin, significantly…
Read More...

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at strengthening capabilities in the rapidly growing field of antibody-drug…
Read More...

UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia, marking a significant step in the company’s long-term U.S. expansion…
Read More...

LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of a broader contract development and manufacturing organization (CDMO)…
Read More...

Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio Therapeutics Inc. to advance the manufacturing of regulatory T-cell (Treg)…
Read More...

BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility at Flatiron Park in Boulder, marking a significant expansion for the…
Read More...

Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in Athlone, Ireland, a move aimed at increasing production capacity for…
Read More...

AbbVie has unveiled plans to invest $380 million to construct two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago, Illinois campus, expanding…
Read More...

Johnson & Johnson has announced plans to invest more than $1 billion in a next-generation cell therapy manufacturing facility in Montgomery County, Pennsylvania, further…
Read More...

Eli Lilly and Company announced plans to construct a $6.5 billion state-of-the-art manufacturing facility at Generation Park in Houston, Texas. This new site will focus on producing…
Read More...

Boehringer Ingelheim has signed a contract development and manufacturing agreement with AnGes Inc. to produce the drug substance for AnGes' investigational Hepatocyte Growth Factor…
Read More...

GSK announced that the U.S. Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix, the company’s vaccine for the prevention of shingles…
Read More...

Thermo Fisher Scientific and Sanofi have announced an expansion of their strategic partnership, aimed at boosting domestic pharmaceutical manufacturing in the United States. As part of…
Read More...

Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), announced an international collaboration with…
Read More...

Global pharma major Lupin Limited (Lupin) announced that it has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialization of Tiotropium…
Read More...

Capsida Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for CAP-003, its potential best-in-class…
Read More...